Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.54 EUR | 0.00% | -6.10% | +2.97% |
Feb. 20 | Stef: SPFA crosses the 10% threshold | CF |
Jan. 03 | Equasens to Acquire 70% Stake in Digipharmacie | MT |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 18.28 | 16.33 | 17.44 | 21.97 | 17.05 | 17.3 | 17.3 | - |
Enterprise Value (EV) 1 | 2.679 | 7.129 | 5.936 | -2.542 | -4.484 | 13.9 | 13.3 | 12.7 |
P/E ratio | -4.48 x | -14.7 x | -2.12 x | 31.8 x | 32.1 x | 139 x | 185 x | 111 x |
Yield | 8.99% | - | - | 7.14% | 19.6% | 9.03% | 9.03% | 9.03% |
Capitalization / Revenue | 0.51 x | 0.51 x | 0.6 x | 0.92 x | 2.65 x | 2.93 x | 3.85 x | 3.68 x |
EV / Revenue | 0.07 x | 0.22 x | 0.2 x | -0.11 x | -0.7 x | 2.36 x | 2.96 x | 2.7 x |
EV / EBITDA | -1.58 x | 10.2 x | 4.57 x | 1.84 x | - | - | - | - |
EV / FCF | -0.8 x | -15.6 x | 9.76 x | - | - | 27.8 x | 19 x | 63.5 x |
FCF Yield | -125% | -6.42% | 10.2% | - | - | 3.6% | 5.26% | 1.57% |
Price to Book | 0.44 x | 0.4 x | - | - | - | 0.64 x | 0.68 x | 0.72 x |
Nbr of stocks (in thousands) | 3,288 | 3,272 | 3,241 | 3,138 | 3,122 | 3,123 | 3,123 | - |
Reference price 2 | 5.560 | 4.990 | 5.380 | 7.000 | 5.460 | 5.540 | 5.540 | 5.540 |
Announcement Date | 4/17/19 | 3/30/20 | 2/4/21 | 4/19/22 | 4/28/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 36 | 32.2 | 29.1 | 24 | 6.432 | 5.9 | 4.5 | 4.7 |
EBITDA 1 | -1.7 | 0.7 | 1.3 | -1.379 | - | - | - | - |
EBIT 1 | -3.1 | -1.4 | -8.4 | -2.6 | -0.618 | -0.5 | -0.5 | -0.4 |
Operating Margin | -8.61% | -4.35% | -28.87% | -10.83% | -9.61% | -8.47% | -11.11% | -8.51% |
Earnings before Tax (EBT) | -3.798 | -1.47 | - | - | - | - | - | - |
Net income 1 | -4.1 | -1.1 | -8 | 0.7 | 0.532 | 0.1 | 0.1 | 0.1 |
Net margin | -11.39% | -3.42% | -27.49% | 2.92% | 8.27% | 1.69% | 2.22% | 2.13% |
EPS 2 | -1.240 | -0.3400 | -2.540 | 0.2200 | 0.1700 | 0.0400 | 0.0300 | 0.0500 |
Free Cash Flow 1 | -3.343 | -0.458 | 0.608 | - | - | 0.5 | 0.7 | 0.2 |
FCF margin | -9.29% | -1.42% | 2.09% | - | - | 8.47% | 15.56% | 4.26% |
FCF Conversion (EBITDA) | - | - | 46.77% | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | 500% | 700% | 200% |
Dividend per Share 2 | 0.5000 | - | - | 0.5000 | 1.070 | 0.5000 | 0.5000 | 0.5000 |
Announcement Date | 4/17/19 | 3/30/20 | 2/4/21 | 4/19/22 | 4/28/23 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - | - |
Net Cash position 1 | 15.6 | 9.2 | 11.5 | 24.5 | 21.5 | 3.4 | 4 | 4.6 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | -3.34 | -0.46 | 0.61 | - | - | 0.5 | 0.7 | 0.2 |
ROE (net income / shareholders' equity) | -9.03% | -2.69% | -0.63% | -5.92% | - | 0.4% | 0.3% | 0.6% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share 2 | 12.80 | 12.60 | - | - | - | 8.640 | 8.160 | 7.710 |
Cash Flow per Share 2 | -0.8600 | 0.0900 | 0.7200 | -0.4500 | 0.1100 | 0.1900 | 0.1700 | 0.1800 |
Capex 1 | 1.22 | 0.76 | 0.79 | - | - | 0.3 | 0.3 | 0.3 |
Capex / Sales | 3.4% | 2.37% | 2.71% | - | - | 5.08% | 6.67% | 6.38% |
Announcement Date | 4/17/19 | 3/30/20 | 2/4/21 | 4/19/22 | 4/28/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.97% | 18.47M | |
+77.49% | 11.41B | |
-12.79% | 10.07B | |
-17.73% | 2.95B | |
+11.22% | 2.8B | |
-11.24% | 2.59B | |
-19.70% | 2.44B | |
0.00% | 2.22B | |
-8.46% | 1.85B | |
-7.20% | 1.25B |
- Stock Market
- Equities
- ALHF Stock
- Financials HF Company